Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!

od Thum, Thomas, Springer, Jochen
Izdano 2011

Evidence for an effect of ACE inhibitors on cancer cachexia

od Schanze, Nancy, Springer, Jochen
Izdano 2012

Bile acids for cachexia therapy: Reply to the letter by Shailendra Kapoor: Ursodeoxycholic acid and its emerging role in attenuation of tumor growth in gastrointestinal malignancie...

od Tschirner, Anika, Springer, Jochen
Izdano 2012

MicroRNAs in muscle wasting

od Suzuki, Tsuyoshi, Springer, Jochen
Izdano u J Cachexia Sarcopenia Muscle (2019)

Biomarkers for cancer cachexia: where do we stand?

od Palus, Sandra, Springer, Jochen
Izdano u J Cachexia Sarcopenia Muscle (2020)

Physical activity for the prevention and treatment of sarcopenic obesity

od Saitoh, Masakazu, Ishida, Junichi, Springer, Jochen
Izdano u J Cachexia Sarcopenia Muscle (2017)

Single‐nucleotide polymorphisms in cachexia‐related genes: Can they optimize the treatment of cancer cachexia?

od Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Izdano u J Cachexia Sarcopenia Muscle (2017)

Is cardiac wasting accompanied by skeletal muscle loss in breast cancer patients receiving anticancer treatment?

od Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Izdano u J Cachexia Sarcopenia Muscle (2017)

Considering technique of assessment and method for normalizing skeletal muscle mass

od Saitoh, Masakazu, Ishida, Junichi, Springer, Jochen
Izdano u J Cachexia Sarcopenia Muscle (2017)

Skeletal muscle wasting in chronic heart failure

od Suzuki, Tsuyoshi, Palus, Sandra, Springer, Jochen
Izdano u ESC Heart Fail (2018)

Muscle Wasting and Sarcopenia in Heart Failure—The Current State of Science

od Lena, Alessia, Anker, Markus S., Springer, Jochen
Izdano u Int J Mol Sci (2020)

Muscle wasting: an overview of recent developments in basic research

od Palus, Sandra, von Haehling, Stephan, Springer, Jochen
Izdano 2014

Blocking myostatin: muscle mass equals muscle strength?

od Anker, Markus S., von Haehling, Stephan, Springer, Jochen
Izdano u J Cachexia Sarcopenia Muscle (2020)

Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment

od Drescher, Cathleen, Konishi, Masaaki, Ebner, Nicole, Springer, Jochen
Izdano u J Cachexia Sarcopenia Muscle (2015)

Hypermetabolism: should cancer types, pathological stages and races be considered in assessing metabolism and could elevated resting energy expenditure be the therapeutic target in...

od Ishida, Junichi, Konishi, Masaaki, Saito, Masakazu, Springer, Jochen
Izdano u J Cachexia Sarcopenia Muscle (2015)

Concern regarding quality and quality of muscle

od Saitoh, Masakazu, Ishida, Junichi, Konishi, Masaaki, Springer, Jochen
Izdano u J Cachexia Sarcopenia Muscle (2015)

Irisin – a myokine potentially bridging muscle and fat tissue in cachexia

od Konishi, Masaaki, Ishida, Junichi, Saito, Masakazu, Springer, Jochen
Izdano u J Cachexia Sarcopenia Muscle (2015)

The concept that focuses on oral motor and feeding function in cancer patients with muscle wasting: Skeletal muscle mass is associated with severe dysphagia in cancer patients

od Saitoh, Masakazu, Ishida, Junichi, Konishi, Masaaki, Springer, Jochen
Izdano u J Cachexia Sarcopenia Muscle (2016)

Growth differentiation factor‐15 as a prognostic biomarker in cancer patients

od Ishida, Junichi, Konishi, Masaaki, Saitoh, Masakazu, Springer, Jochen
Izdano u J Cachexia Sarcopenia Muscle (2016)

Clinical perspective for wasting in diaphragm, an ever‐trained muscle

od Konishi, Masaaki, Ishida, Junichi, Saitoh, Masakazu, Springer, Jochen
Izdano u J Cachexia Sarcopenia Muscle (2016)